Peters Anne, Van Name Michelle A, Thorsted Brian Larsen, Piltoft Johanne Spanggaard, Tamborlane William V
Endocr Pract. 2017 Oct;23(10):1201-1209. doi: 10.4158/EP171813.OR. Epub 2017 Jul 13.
To assess the prevalence and characteristics of patients with type 1 diabetes (T1D) who dose bolus insulin postprandial (PostP) versus preprandial (PreP).
Data for this cross-sectional study were obtained from 21,533 participants in the T1D Exchange Registry. Data were drawn from the enrollment questionnaire. Patients who dosed 'immediately before meal' or 'several minutes before meal' were classified as PreP. Patients who dosed 'during meal' or 'after meal' were classified as PostP. Data reported (PostP vs. PreP) are mean ± SD and percentage, as appropriate.
After exclusion of patients who did not answer the dose-timing question or who selected 'not given regularly' or 'depends on glucose level prior to meal,' (4,229 of 25,762), 21,533 patients were included in the study. Ninety-nine percent of patients used rapid-acting insulin analogues; 32% dosed insulin PostP. Compared to PreP, children <18 years of age dosing PostP were characterized by higher glycated hemoglobin (HbA1c) (8.7 ± 1.5% [72 ± 16.4 mmol/mol] vs. 8.4 ± 1.7% [68 ± 18.6 mmol/mol]), larger insulin dose (1.2 ± 0.7 IU/kg/day vs. 1.1 ± 0.7 IU/kg/day), greater prevalence of history of hypoglycemia, and diabetic ketoacidosis. Adults who dosed PostP were characterized by younger age (33.0 ± 15.3 years vs. 39.5 ± 16.6 years), higher HbA1c (8.3 ± 1.5% [67 ± 16.4 mmol/mol] vs. 7.8 ± 1.5% [62 ± 16.4 mmol/mol]), and larger insulin dose (1.0 ± 0.6 IU/kg/day vs. 0.9 ± 0.5 IU/kg/day) than PreP.
This study reveals that a large proportion of patients dose bolus insulin PostP. Despite the use of current rapid-acting insulin analogues, patients who dose PostP are characterized by poorer glycemic control in all patients and a greater prevalence of history of severe hypoglycemia and diabetic ketoacidosis in children.
BMI = body mass index; CGM = continuous glucose monitoring; DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; PostP = postprandial; PreP = preprandial; SMBG = self-monitored blood glucose; T1D = type 1 diabetes.
评估1型糖尿病(T1D)患者餐后(PostP)与餐前(PreP)注射大剂量胰岛素的患病率及特征。
本横断面研究的数据来自T1D交换登记处的21,533名参与者。数据取自入组问卷。在“饭前立即”或“饭前几分钟”注射胰岛素的患者被归类为PreP。在“用餐期间”或“用餐后”注射胰岛素的患者被归类为PostP。所报告的数据(PostP与PreP对比)在合适的情况下为均值±标准差及百分比。
排除未回答注射时间问题或选择“不定期注射”或“取决于餐前血糖水平”的患者(25,762名中的4,229名)后,21,533名患者纳入本研究。99%的患者使用速效胰岛素类似物;32%的患者餐后注射胰岛素。与PreP相比,餐后注射胰岛素的18岁以下儿童糖化血红蛋白(HbA1c)更高(8.7±1.5% [72±16.4 mmol/mol] 对比8.4±1.7% [68±18.6 mmol/mol])、胰岛素剂量更大(1.2±0.7 IU/kg/天对比1.1±0.7 IU/kg/天)、低血糖病史及糖尿病酮症酸中毒患病率更高。餐后注射胰岛素的成人特征为年龄更小(33.0±15.3岁对比39.5±16.6岁)、HbA1c更高(8.3±1.5% [67±16.4 mmol/mol] 对比7.8±1.5% [62±16.4 mmol/mol])、胰岛素剂量更大(1.0±0.6 IU/kg/天对比0.9±0.5 IU/kg/天)。
本研究显示,很大一部分患者餐后注射大剂量胰岛素。尽管使用了目前的速效胰岛素类似物,但餐后注射胰岛素的患者在所有患者中血糖控制较差,且儿童严重低血糖病史及糖尿病酮症酸中毒患病率更高。
BMI = 体重指数;CGM = 持续葡萄糖监测;DKA = 糖尿病酮症酸中毒;HbA1c = 糖化血红蛋白;PostP = 餐后;PreP = 餐前;SMBG = 自我血糖监测;T1D = 1型糖尿病